SkinJect
Pharmaceuticals - Pittsburgh, Pennsylvania, United States
SkinJect Employees
SkinJect Details
Skinject, Inc. is developing a novel drug delivery system for the treatment of non-melanoma skin cancers.The system comprises a dissolvable microneedle array (MNA) to deliver a drug directly into the top layer of skin. The drug will kill non-melanoma skin cancer by causing an immune system reaction to combat the disease.SkinJect consists of three key components:- Dissolvable microneedles that penetrate the skin, dissolve and deliver the "cargo" − the drug.- A cellulose-like material that forms the microneedles and carries the cargo. It is FDA-approved for human use.- A chemotherapy cargo that kills cells and also stimulates an immunological response from the patient's lesion. Also FDA-approved for human use.
SkinJect Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Tag Management
Google Tag Manager
Other
Microsoft Office 365
Analytics and Tracking
Google Analytics